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1. Introduction 
In molecular biology and genetics, mutations are described as sudden and spontaneous or 
induced changes in a genomic sequence (Brown, 2007). They have wide effects on all living 
organisms from bacteria with a single prokaryotic cell construction to multicellular and 
eukaryotic organisms including human being with high-level cellular differentiation. 
Mutations occur also in the genomic materials (DNA or RNA) of viruses and affect their 
functionality (Hartl & Jones, 1998; Lewin, 2004). When a mutation happens, it can basically 
result in several different types of change in DNA (or RNA for some viruses) sequences; these 
can have no effect, alter the product of gene, and prevent the gene from functioning properly 
or completely. Alterations in the product of gene and partial or total loss of gene function 
generally result in a disadvantageous situation for the organism, which cause various 
symptoms and ailments affect the maintenance of life (Brown, 2007). Previous studies made to 
understand the relations between mutations and their negative effects on human being clearly 
showed that some diseases, such as most forms of cancer, heart disease and mental disorders, 
have a partly or completely genetic basis closely related to mutagenesis (Bertram, 2000; Alberts 
et al., 2002; Lodish et al., 2007). Therefore, recent investigations have mainly focused on 
mutation classification, understanding mutagenesis mechanisms, determination of mutagenic 
agents and prevention strategies (Cox, 1976; Albertini et al., 1990; Davidson et al., 2002; 
Akiyama, 2010; Evans et al., 2010; Gulluce et al., 2010; Lynch, 2010; Waters et al., 2010; Lange et 
al., 2011; Loeb, 2011; Pao & Girard, 2011). Thus, the identification of substances capable of 
inducing mutations has become an important procedure in safety assessment. In the research 
studies, mutations can be divided in two main groups to get more comprehensive results 
according to their size. First group is described as gene mutations, where only single base is 
modified, or one or a relatively few bases are inserted or deleted (Brown, 2007). Other one 
consists of chromosome mutations, which are including chromosome breaks, large deletions, 
rearrangements, or gain or loss of whole chromosome (Hartl & Jones, 1998; Lewin, 2004).  
Mutation test systems also divide in long-term and short-term systems according to 
obtaining of the results (Wickramasnghe, 1979; Mortelmans & Zeiger, 2000; Zeiger et al., 
2005). The long-term mutagenicity tests, which use in vivo researches with various 
experimental animals, give more reliable results than short-term mutagenicity test systems. 
However, they are not preferred as beginning test systems due to their high cost and long 
time requirements, where mutagenic potential of many synthetic and natural chemicals are 
checked (Wickramasnghe, 1979; Gulluce et al., 2010). In these studies, the short-term test 
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systems, which eliminate disadvantages of the long-term test systems, are more suitable and 
acceptable. Many short-term studies result in gaining reliable and alternative data under 
controlled in vitro conditions. Another important advantage is that short-term mutation test 
systems are not only correlated with other short-term test systems, but also long-term 
systems (Mortelmans & Zeiger, 2000). Thus, the combinations of the mutagenicity test 
systems play a key role to get more meaningful results.  
The bacterial mutation assays are known as most important short-term systems in order to 
determine mutagenic and antimutagenic potential of natural or synthetic chemicals related to 
gene mutations (Ames et al., 1973a, 1973b; Maron & Ames, 1983; Mortelmans & Riccio, 2000; 
Mortelmans & Zeiger, 2000). The Salmonella bacterial reverse mutation assay is one of the 
simplest, the most meaningful and acceptable short-term mutagenicity and antimutagenicity 
test systems. The test was initially developed by Ames in 1971. Therefore, it is also called as the 
Ames mutagenicity assay or the Ames/Salmonella mutagenicity assay (Ames et al., 1973a, 
1973b; Maron & Ames, 1983; Zeiger, 2004, 2010). The main advantages of the assay, which 
employs mutant Salmonella typhimurium tester strains as model prokaryotic organisms, can be 
ordered as inexpensive applications enable studying a large number of test materials, quickly 
resulting (approximately 48 hours) allows making replicates in a short time, divers tester 
strains with several gene mutations allow to research the molecular effect mechanism of test 
materials, additional mutations in each strain result in more sensitivity such as rfa or uvrB and 
mesophile character of Salmonella allows to study several test materials affective at human 
body temperature. Furthermore, combination of the cytochrome-based P450 metabolic 
oxidation system, which usually consists of a 9000×g supernatant fraction of a rat liver 
homogenate (S-9 microsomal fraction), with the Salmonella mutagenicity test allows to 
determine some mutagenic agents, which are biologically inactive unless they are metabolized 
to active forms (Ames et al., 1973b; Mortelmans & Zeiger, 2000; Zeiger et al., 2005). Thus, the 
assay is used world-wide in genetic toxicology laboratories as a beginning mutation test to 
determine mutagenic and antimutagenic potentials of various chemicals. 
The present study includes an introduction to use of Salmonella strains in genetic toxicology, 
principles of Salmonella bacterial reverse mutation assay, the most popular assay procedures 
with explanatory figures and clues for experimental design.  
2. Scientific background 
2.1 Mutations and their effects on living organisms 
Genetic materials of all living organisms are dynamic structures that change and rearrange 
many times as a result of cumulative effects of mutations. Mutations, described as sudden 
and spontaneous or induced changes in a genomic sequence, are classified in two main 
groups depend on their physical effect sizes on the genome (Hartl & Jones, 1998; Lewin, 
2004; Klug et al., 2005; Brown, 2007). First group is large-scale mutations in chromosomal 
level, including numerical and structural anomalies. Numerical anomalies are also called as 
aneuploidy, means an abnormal number of chromosomes. The most known examples for 
aneuploidy are monosomy (missing a chromosome from a pair), nullisomy (missing a pair 
of chromosomes), trisomy and polysomy (having one or more than two chromosomes of a 
pair). Down and Turner syndromes are important examples related to chromosomal 
anomalies in humans. An individual with Down syndrome has a developmental disorder 
caused by having three copies of chromosome 21. Therefore, it is also called as Trisomy 21. 
www.intechopen.com
 
Salmonella as a Unique Tool for Genetic Toxicology 
 
257 
Another disorder is Turner syndrome, an example of a monosomy where the individual is 
born with only one X chromosome (Klug et al., 2005).  
Structural anomalies of the large-scale mutations include deletions, duplications, inversions 
and translocations. A deletion is a loss of one or more pieces from a chromosome after DNA 
breaks induced by various physical or chemical agents (Klug et al., 2005). Genetic information 
loss together with deletions causes serious disorders in humans, for example, Wolf-Hirschhorn 
syndrome, also known as deletion 4p syndrome, and Jacobsen syndrome, also known as 
deletion 11q syndrome (Hirschhorn et al., 1965; Jacobsen et al., 1973). Duplication is described 
as a phenomenon that a chromosome has extra copies of a chromosomal region, which may 
affect phenotype by altering gene function and transcriptional dosage (Zhang, 2003; Mao & 
Pevsner, 2005). Because most embryonic processes requires sensitively balanced protein levels, 
many duplications lead to developmental defects such as Bar eye mutation in Drosophila and 
Charcot-Marie-Tooth disease in humans (Sutton, 1943; Latour et al., 1997). An inversion type 
chromosomal mutation occurs when a portion of the chromosome breaks off, 180° rotates and 
reattaches, resulting in an inverted genetic material. There is little knowledge about the linkage 
between inversions and disease formation, and it is believed that many affect mechanisms of 
inversions directly associated with deletions. Juvenile Polyposis of Infancy, a rare genetic 
disorder, is a good example for a disease evolved by the cumulative effects of inversions (a 
paracentric inversion in 10q) and deletions (a deletion in 10p) (Gimelli et al., 2003; Antonacci et 
al., 2009; Vargas-Gonzales et al., 2010). The last group of the structural anomalies is 
translocations, defined as an exchange of segments among the non-homologues chromosomes. 
Several forms of cancer, leukemia and lymphoma are the best known disorders related to 
translocations (Li et al., 1999; Kurzrock et al., 2003; Anton et al., 2004). Figure 1 illustrates 
structural chromosome mutations. 
 
Fig. 1. Structural chromosome mutations 
Small-scale mutations, also known as gene mutations, include three main groups: point 
mutations, which are the most common type of the gene mutations and replace one 
nucleotide with another, insertions, which add one or a few extra nucleotides into the DNA, 
and deletions, which remove one or a few nucleotides from the DNA (Brown, 2007). 
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Point mutations are also divided into two categories as transitions and transversions. 
Transitions, which are purine-to-purine or pyrimidine-to-pyrimidine changes (A↔G or 
C↔T), are more common type of the point mutations than transversions, which are purine-
to-pyrimidine or pyrimidine-to-purine changes (A↔C, A↔T, G↔C or G↔T) (Brown, 2007).  
Contrary to “small-scale” word in their names, these mutations can cause wide-range 
significant changes in genomes and phenotypes of living organisms with mutated genetic 
materials. For example, a point mutation may result in a synonymous change that causes 
forming a new codon specifying the same amino acid as the unmutated codon, a non-
synonymous change that causes a missense mutation where a new codon specifies a different 
amino acid from the unmutated codon, a nonsense mutation where the change converts an 
amino acid specifying codon into a termination codon, or a readthrough mutation where the 
change converts a termination codon into an amino acid specifying codon. Except synonymous 
changes, also called as silent mutations because the mutated gene codes for exactly the same 
protein as the unmutated gene, the other three types of point mutations have significant 
impacts on the genome and related phenotypes by effecting amino acid sequence of the coding 
protein (Hartl & Jones, 1998; Alberts et al., 2002; Lewin, 2004; Brown, 2007; Lodish et al., 2007). 
The effects of point mutations on the coding region of a gene are shown in Figure 2. 
 
Fig. 2. The effects of point mutations on the coding region of a gene (Brown, 2007). 
Insertion and deletion types of small-scale mutations affect the coding capabilities of the 
gene in a different way. It is defined as a frameshift mutation, caused by addition or 
deletion of a number of nucleotides that is not evenly divisible by three from a DNA 
sequence. Because codons consist of three nucleotides, an insertion or deletion type 
mutation can disrupt the reading frame, resulting in a completely different translation from 
the unmutated gene. Thus, insertion or deletion mutations generally have more significant 
effects on the protein function than the point mutations because the translated protein have 
completely different sequence from the mutated point to the end. An exception occurs that 
the number of inserted or deleted nucleotides is three or a multiple of three, which results in 
addition or deletion of one or more codons (Alberts et al., 2002; Lewin, 2004; Brown, 2007; 
Lodish et al., 2007). Figure 3 illustrates two possible effect mechanisms of the insertion or 
deletion type mutations on the coding region of a gene. 
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Fig. 3. Two possible effect mechanisms of the insertion or deletion type mutations on the 
coding region of a gene (Brown, 2007). 
Phenotypic results of mutations can be deleterious or advantageous for the affected 
organism. Many hereditable disorders are either directly caused by the mutations or 
indirectly associated with the mutagenesis. Cancer formation can be given as a satisfactory 
example to demonstrate deleterious effect of mutations. Recent studies clearly showed that 
there is a strict connection between mutagenesis and the formation of the several cancer 
types (Davidson et al., 2002). In this manner, mutations provide a unique resource for all 
tumors that show genomic instability with few exceptions. On the other hand, mutated 
organisms can gain various advantages as a result of mutagenesis. Gain of antibiotic 
resistance in microorganisms and HIV/AIDS protective mutations on the SDF1, CCR5 and 
CCR2 genes in the human genome are well examples for the advantageous mutations 
(Stephan et al., 1998; Galvani & Slatkin, 2003; Apostolakis et al., 2005). These are also very 
important for evaluation of the organisms. Therefore, mutagenesis can be considered as one 
of the most important evolutionary sources. For example; simple sequence repeats (SSRs, 
also called microsatellites and minisatellites) are defined as advantageous mutators in 
adaptive evolution. Recent studies showed that temperature compensation of circadian 
rhythm in Drosophila, adaptive divergence among barley and wheat populations, social 
behavior in voles, skeletal morphology in domestic dogs and sporulation efficiency and cell 
adhesion in yeast are closely related to SSRs, which are mutation-prone DNA tracts 
composed of tandem repetitions of relatively short motifs (Kashi & King, 2006). 
2.2 The causes of mutations 
Mutations are divided into spontaneous and induced alterations according to their 
formation sources. Spontaneous mutations arise from replication errors due to defective 
replication enzymes and alternative tautomer forms of nucleotide bases. These are rare 
types of mutations. On the other hand, induced mutations, common types of mutations, are 
caused by various mutagens. In the molecular mechanism of induced mutations, a physical 
or chemical mutagen reacts with the DNA strand, causing a structural change that affects 
the base-pairing capability of the altered nucleotide. The most important types of physical 
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mutagens are ultraviolet radiation of wavelength 260 nm, ionizing radiation and heat shock. 
However, base analogs such as 5-bromouracil (5-bU), deaminating agents such as nitrous 
acid, alkylating agents such as ethylmethane sulfonate (EMS) and intercalating agents such 
as (ethidium bromide) are the most well-known chemical mutagen classes (Brown, 2007).  
Chemical mutagens are more frequent agents because thousands of natural or synthetic 
chemicals have been introduced for daily use in many areas including medicine, pharmacy, 
food and cosmetics. The count of new chemicals is increasing day-by-day, and each 
chemical can be considered as a potential mutagen before tested. Therefore, many test 
systems for detecting of chemical mutagens have been developed and frequently used in the 
laboratories around the world (Zieger, 2000; World Health Organization [WHO], 2007).  
2.3 The mutagenicity and antimutagenicity test systems 
The deleterious effects of mutations enforce the determination of mutagenic chemicals. There 
are many assay systems for this purpose, and a new chemical is tested for mutagenic potential 
before introduced to use. The main groups of the assay systems are long-term and short-term 
assay systems (Wickramasnghe, 1979; Zeiger et al., 2005; Mortelmans & Zeiger, 2000). 
The long-term assay systems mainly include in vivo applications performed with experimental 
animals. These are the most comprehensive and reliable test systems. However, the long-term 
assay systems are not preferred as the beginning mutation test systems due to their high—cost 
and time consuming properties (Wickramasnghe, 1979; Zeiger et al., 2005). 
On the other hand, the short-term assay systems mainly include in vitro assays performed 
with bacterial strains, cytological cell-line cultures and biotechnology based applications. 
Relatively inexpensive and time-saver nature of the short-term assay systems makes them 
good candidates for preliminary mutagen determination studies performed with fairly huge 
numbers of synthetic or natural chemicals. Furthermore, these assays can identify 
substances inhibiting mutagens and mutations (called as antimutagens) with some 
modifications. Therefore, a mutagenicity test system can be also considered as 
antimutagenicity test system (Ames et al., 1973a, 1973b; Wickramasnghe, 1979; Fenech, 2000; 
Maron & Ames, 1983; Mortelmans & Riccio, 2000; Mortelmans & Zeiger, 2000; Zeiger et al., 
2005; Rossi et al., 2007; Ozbek et al., 2008a, 2008b; Gulluce et al., 2010). 
2.4 Ames/Salmonella test system 
The Ames/Salmonella test system, also called as Ames test, was developed by Ames et al. in 
the beginning of 1970s. The test, which employs histidine auxotroph Salmonella strains 
originated from Salmonella typhimurium LT-2 by chemical and radiation induced mutations, 
was initially designed as a spot test for determination of mutagenic chemicals, then as a 
more sensitive method: plate incorporation test (Ames et al., 1973a, 1973b; Maron & Ames, 
1983; Gee et al., 1994; Mortelmans & Zeiger, 2000; Tijs, 2008).  
In the molecular mechanism of the test system, a tester strain carries a unique gene mutation 
at the histidine operon that makes the strain histidine-dependent to grow, and a mutagenic 
chemical reacts with the mutated site resulting in a reverse mutation. Thus, the strain 
regains histidine production ability and the bacterial cells can grow in the absence of 
histidine. Therefore, the test is often referred as a reversion assay (Ames et al., 1973a, 1973b; 
Maron & Ames, 1983; Gee et al., 1994; Mortelmans & Zeiger, 2000; Tijs, 2008). 
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After its introduction to the scientific world, Ames test has been widely accepted as a short-
term bacterial test system for determining chemicals that can cause gene mutations. The test 
has many advantages for identification of the chemicals that cause gene mutations. These 
advantages can be listed in: 
 Short-term resulting: allows making replicates and obtaining more reliable results in a 
short duration. It takes only about 48 hours.  
 Low-cost: allows studying a large number of test materials inexpensively.  
 Various tester strains with several gene mutations: enable to research the molecular 
effect mechanism of test materials 
 Additional mutations and genetic alterations: allow gaining more sensitivity for various 
chemicals. 
 Mesophile character of Salmonella strains: enables to study mutagenic potential of the 
chemicals at human body temperature.  
Apart from all the maintained advantages, Ames/Salmonella test system is very versatile, 
and many modifications has been developed to determine mutagenic potencies of various 
materials such as environmental chemicals, environmental mixtures, body fluids, foods, 
drugs and physical agents. The most common assay procedures are the spot test: a primal 
method for determination of chemical mutagens, the standard plate incorporation method: 
an easily resulting and more comprehensive method than the spot test, the pre-incubation 
method: developed for performing more effective studies with lower volumes of test 
materials, the desiccator assay modifications: developed to study volatile materials and 
gases, and the modified Salmonella microsuspension assay (Kado): a highly sensitive method 
for testing the materials that are available only in small amounts (Kado et al., 1983; Hughes 
et al., 1987; Zeiger et al., 1992; Araki et al., 1994; Mortelmans & Zeiger, 2000; Tijs, 2008). 
Although Salmonella has prokaryotic cell structure, combination of the cytochrome-based 
P450 metabolic oxidation system with the Ames/Salmonella test system allows determining 
some mutagenic agents, which are biologically inactive unless they are metabolized to active 
forms (Ames et al., 1973b; Mortelmans & Zeiger, 2000). Moreover, all the procedures of the 
test system can be altered to identify antimutagenic agents, inhibit mutagenesis and protect 
the organisms against deleterious effects of the mutagens, with some modifications 
(Nagabhushan et al., 1987; Bala & Grover, 1989; Edenharder et al., 1999; Edenharder & 
Grünhage, 2003; Ozbek et al., 2008a, 2008b; Gulluce et al., 2010) (see 3.8).  
3. Material and methods 
3.1 Supplies and equipment 
The following items are required for performing the Ames/Salmonella mutagenicity and 
antimutagenicity protocols. 
3.1.1 Supplies  
 Magnetic stir bars 
 Sterile glass test tubes (100×16 mm) and racks 
 Sterile microbiological loops 
 Sterilizing membrane filters (0.2 µm) 
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 Sterile syringes (5, 10 and 50 ml) 
 Sterile Petri dishes (100×15 mm) 
 Disposable spectrophotometer cuvettes 
 Solvents, reagents, media and positive control chemicals 
 General laboratory glassware (bottles, flasks and graduated cylinders)  
 Dispensers for delivering top agar, buffer and S-9 mix to the test tubes 
 Sterile cryogenic storage vials for freezing down permanent and working cultures 
 General laboratory safety items (biohazard waste bags, goggles or protective eye wear, 
gloves, lab coats) 
 Glass pipettes (1, 2, 5 and 10 ml), automatic micropipettes (adjustable volumes up to 200 
and 500 µl) and pipette tips 
3.1.2 Equipment  
 Autoclave 
 Manual or electronic colony counter 
 Spectrophotometer for monitoring cell density 
 Centrifuge (up to 8000 rpm) 
 Liquid and solid waste disposal 
 Magnetic stirrers 
 Desiccator and vacuum pump 
 Balances 
 Biological/chemical safety cabinet equipped with gas line for keeping aseptic 
techniques while inoculating cultures 
 Ultra-low temperature freezer set at -86 °C or liquid nitrogen tank for long term storage 
of frozen permanent cultures 
 Refrigerator (4 °C) and freezer (-20 °C) 
 Water purification system to generate distilled water 
 Water bath set at 43 °C to 48 °C to maintain temperature of top agar 
 Incubator for incubating the agar plates 
 Shaking incubator for incubating the liquid cultures and growing the overnight cultures 
 Boiling water bath or microwave oven for melting top agar 
3.2 Reagents and media  
Glucose solution (10% w/v): The solution is used as carbon source for the GM agar plates. 
Dissolve 100 g dextrose (D-glucose) in 700 ml of distilled water by stirring on a magnetic 
stirrer. Add additional water to bring the final volume to 1000 ml and distribute in 50 ml 
aliquots. Autoclave 121 °C for 20 min and store at 4 °C. 
Vogel-Bonner medium E (VB salts 50×): The solution is used as salt source for the GM agar 
plates. Add 10 g magnesium sulfate (MgSO4·H2O), 100 g citric acid monohydrate 
(C6H8O7·H2O), 500 g potassium phosphate dibasic (K2HPO4) and 175 g sodium ammonium 
phosphate (Na2NH2PO4·4H2O) in the order indicated to 650 ml of warm water making sure 
that each salt is dissolved thoroughly by stirring before adding the next salt. Add additional 
water to bring the final volume to 1000 ml and distribute in 20 ml aliquots. Autoclave 121 °C 
for 30 min and store at room temperature in the dark. 
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GM agar plates: The medium is used as bottom agar for mutagenicity and antimutagenicity 
assays. Add 15 g agar to 900 ml of distilled water and autoclave for 30 min at 121 °C. When 
cooled to approximately 65 °C, add 20 ml of sterile Vogel-Bonner medium E and mix well; 
then add 50 ml of sterile glucose solution and mix thoroughly. Pour nearly 25 ml of the 
medium into sterile 100×15 mm petri dishes and store at 4 °C for several weeks by packing 
with sealed plastic bags after solidified. Note that the plates should be warmed up to room 
temperature and examined for excess moisture before use. Put the plates with too much 
moisture overnight in an incubator set at 37 °C prior to use.  
Histidine/biotin solution (0.5 mM): The solution is used to supplement top agar with adequate 
biotin and a trace amount of histidine. Dissolve 124 mg D-biotin and 96 mg L-histidine·HCl in 
1000 ml of boiling water. Sterilize the solution by filtration through a membrane filter with 0.2 
µm pore size or autoclaving for 20 min at 121 °C. Store at 4 °C in a glass bottle. 
Top agar supplemented with histidine/biotin: The solution is used to apply the bacteria, 
chemicals and buffer or S9 mix to the bottom agar. Dissolve 6 g agar and 6 g sodium 
chloride (NaCl) in 900 ml of distilled water by heating. Add 100 ml of histidine/biotin 
solution (0.5 mM) and dispense 200 ml aliquots in screw-cap bottles. Autoclave for 20 min at 
121 °C and store at room temperature in the dark. Melt the top agar in a microwave oven or 
boiling water bath before use. 
Nutrient broth: Oxoid nutrient broth no. 2 or Difco nutrient broth can be used to grow the 
tester strains overnight. Follow the manufacturer’s instructions for preparing the medium. 
Dispense 50 ml in Erlen Meyer flasks with 125 ml capacity or 5 ml in 100×16 mm test tubes, 
autoclave for 20 min at 121 °C and store in the dark at room temperature. 
Nutrient agar plates: The medium is used for streaking newly received cultures for single 
colonies, checking crystal violet sensitivity due to presence of rfa mutation and testing viability 
of bacteria. Add 15 g agar to 1000 ml of nutrient broth medium and dissolve by heating. 
Autoclave for 20 min at 121 °C. After cooled to 65 °C, pour nearly 25 ml of the medium into 
sterile 100×15 mm petri dishes and store at 4 °C by packing with sealed plastic bags. 
Sodium phosphate buffer (0.1 mM – pH 7.4): The solution is used to perform mutagenicity and 
antimutagenicity assays in the absence of metabolic activation. In the first step, prepare 
Reagent A (0.1 M sodium phosphate monobasic solution: 13.8 g NaH2PO4·H2O in 1000 ml of 
distilled water) and Reagent B (0.1 M sodium phosphate dibasic reagent: 14.2 g Na2HPO4·H2O 
in 1000 ml of distilled water). After that, mix 120 ml of Reagent A and 880 ml Reagent B and 
swirl well. Adjust pH to 7.4 using Reagent A/B and dispense 100 ml aliquots in screw-cap 
bottles. Autoclave for 30 min at 121 °C and store at room temperature in the dark. 
Metabolic activation system (S-9 mix): The solution is used to perform mutagenicity and 
antimutagenicity assays in the presence of metabolic activation. Moltox metabolic activation 
system products can be used. Follow the manufacturer’s instructions for preparation and 
storage of the related solutions. 
Biotin solution (0.01%, w/v): The solution is used to prepare enriched GM agar plates for 
biotin auxotrophy check. Dissolve 10 mg D-biotin in 100 ml of boiling distilled water. 
Sterilize using a membrane filter with 0.2 µm pore size and store at 4 °C. 
Histidine solution (0.5%, w/v): The solution is used to prepare enriched GM agar plates for 
histidine auxotrophy check. Dissolve 500 mg L-histidine in 100 ml of distilled water. 
Autoclave for 15 min at 121 °C and store at 4 °C. 
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Ampicillin solution (0.8%, w/v): The solution is used to prepare enriched GM agar plates for 
examining presence of plasmid pKM101 in several tester strains such as TA97, TA98, TA100 
and TA102. Dissolve 8 mg ampicillin in 100 ml of warm (65 °C) distilled water and sterilize 
using membrane filter with 0.2 µm pore size. Store at 4 °C. 
Tetracycline solution (0.8%, w/v): The solution is used to prepare enriched GM agar plates for 
examining presence of plasmid pAQ1 in TA102. Dissolve 8 mg tetracycline in 100 ml of 0.02 
N hydrochloric acid (HCl) and sterilize using membrane filter with 0.2 µm pore size. Store at 
4 °C in the dark due to the light sensitivity of tetracycline. 
Enriched GM agar plates: Each medium contains essential nutrients and antibiotics for the 
strain check and preparation of stock cultures’ master plates. 
 Biotin plates (B): Prepare GM agar medium. After autoclaving, add 8 ml of sterile biotin 
solution (0.01%, w/v), mix well and pour nearly 25 ml of the medium into sterile 
100×15 mm petri dishes. 
 Histidine plates (H): Prepare GM agar medium. After autoclaving, add 8 ml of sterile 
histidine solution (0.5%, w/v), mix well and pour nearly 25 ml of the medium into 
sterile 100×15 mm petri dishes. 
 Biotin/histidine plates (BH): Prepare GM agar medium. After autoclaving, add 8 ml of 
sterile biotin solution (0.01%, w/v) and 8 ml of sterile histidine solution (0.5%, w/v), 
mix well and pour nearly 25 ml of the medium into sterile 100×15 mm petri dishes. 
 Biotin/histidine/ampicillin plates (BHA): Prepare GM agar medium. After autoclaving, 
add 8 ml of sterile biotin solution (0.01%, w/v), 8 ml of sterile histidine solution (0.5%, 
w/v) and 3 ml of ampicillin solution, mix well and pour nearly 25 ml of the medium 
into sterile 100×15 mm petri dishes. 
 Biotin/histidine/tetracycline plates (BHT): Prepare GM agar medium. After 
autoclaving, add 8 ml of sterile biotin solution (0.01%, w/v), 8 ml of sterile histidine 
solution (0.5%, w/v) and 0.25 ml of tetracycline solution, mix well and pour nearly 25 
ml of the medium into sterile 100×15 mm petri dishes. 
 Biotin/histidine/ampicillin/tetracycline plates (BHAT): Prepare GM agar medium. After 
autoclaving, add 8 ml of sterile biotin solution (0.01%, w/v), 8 ml of sterile histidine 
solution (0.5%, w/v), 3 ml of ampicillin solution and 0.25 ml of tetracycline solution, mix 
well and pour nearly 25 ml of the medium into sterile 100×15 mm petri dishes. 
Crystal violet solution (0.1%, w/v): The solution is used to confirm the presence of the rfa 
mutation in all of the tester strains. Dissolve 100 mg crystal violet in 100 ml of distilled 
water. Mix well and store at 4°C in an amber glass bottle to protect against light. 
All reagents and solutions, reported here, have been previously described by Mortelmans 
and Zeiger (2000). 
3.3 Bacterial strains  
Salmonella typhimurium TA1535, TA1537, TA1538, TA97, TA98, TA100, TA102 and TA104 are 
the most common tester strains used in the Ames/Salmonella test system. All strains are 
histidine auxotroph because of a mutation in the histidine operon. The tester strains also 
have additional mutations and genetic alterations that provide more sensitivity for chemical 
mutagens. These are uvrB, rfa mutations and introduction of pKM101 and pAQ1 plasmids. 
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The uvrB mutation, which is present in all strains except TA102, arise from a deletion type 
mutation through the uvrB-bio genes that eliminates the accurate DNA repair and makes the 
cells biotin dependent. All strains have the rfa mutation that affects the bacterial cell wall, 
resulting in a defective lipopolysacharide layer that provides more permeability to bulky 
chemicals. Existence of pKM101 plasmid in TA97, TA98, TA100, and TA102 provides 
ampicillin resistance and sensitivity for chemical and induced mutagenesis associated with 
error-prone recombinational DNA repair pathway. TA102 strain also has multicopies of 
pAQ1 plasmid carrying hisG428 mutation, which provides tetracycline resistance and 
sensitivity for detection of DNA cross-linking agents (Mortelmans & Zeiger, 2000). Table 1 
presents genotypes of the tester strains. 
 
Strain DNA Target uvrB rfa Plasmid Reversion Event 
TA1535 
hisG46 
-G-G-G- 
+ + - 
Base-pair 
substitutions 
TA1537 
hisC3067 
-C-C-C- 
+1 frameshift 
+ + - Frameshifts 
TA1538 
hisD3052 
-C-G-C-G-C-G-C-G- 
-1 frameshift 
+ + - Frameshifts 
TA97 
hisD6610 
-C-C-C-C-C-C- 
+1 frameshift 
+ + pKM101 Frameshifts 
TA98 
hisD3052 
-C-G-C-G-C-G-C-G- 
-1 frameshift 
+ + pKM101 Frameshifts 
TA100 
hisG46 
-G-G-G- 
+ + pKM101 
Base-pair 
substitutions 
TA102 
hisG428 
TAA 
(ochre) 
- + 
pKM101 
pAQ1 
Base-pair 
substitutions 
TA104 
hisG428 
TAA 
(ochre) 
+ + - 
Base-pair 
substitutions 
Table 1. Genotypic properties of the most common Salmonella tester strains. 
There are also additional tester strains (TA7001-7006 and TA7041-7046 series), which 
developed by Gee et al. (1994), to identify specific transitional and transversional base-pair 
substitutions induced by various mutagenic agents. Table 2 presents genotypic properties of 
these strains. 
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Strain 
DNA 
Target 
uvrB rfa Plasmid 
Reversion 
Event 
Amino acid change 
TA7001 hisG1775 + + pKM101 AT → GC Asp-153 → Gly-153 
(GAT → GGT) 
TA7002 hisC9138 + + pKM101 TA → AT Ile-217 → Lys-217 
(ATA → AAA) 
TA7003 hisG9074 + + pKM101 TA → GC Val-153 → Gly-153 
(GTT → GGT) 
TA7004 hisG9133 + + pKM101 GC → AT Gly-169 → Asp-169 
(GGG → GAT) 
TA7005 hisG9130 + + pKM101 CG → AT Ala-169 → Asp-169 
(GCG → GAT) 
TA7006 hisC9070 + + pKM101 CG → GC Arg-163 → Gly 163 
(CGA → GGA) 
TA7041 hisG1775 + - pKM101 AT → GC Asp-153 → Gly-153 
(GAT → GGT) 
TA7042 hisC9138 + - pKM101 TA → AT Ile-217 → Lys-217 
(ATA → AAA) 
TA7043 hisG9074 + - pKM101 TA → GC Val-153 → Gly-153 
(GTT → GGT) 
TA7044 hisG9133 + - pKM101 GC → AT Gly-169 → Asp-169 
(GGG → GAT) 
TA7045 hisG9130 + - pKM101 CG → AT Ala-169 → Asp-169 
(GCG → GAT) 
TA7046 hisC9070 + - pKM101 CG → GC Arg-163 → Gly 163 
(CGA → GGA) 
Table 2. Genotypic properties of Salmonella tester strains developed by Gee et al. (1994). 
The test system performed with TA700x tester strains is called as AMES II (Kamber et al., 
2009). The set of TA7041-7046 strains is not suitable to test mutagenic and antimutagenic 
potential of chemicals due to lack of rfa mutation and their instable genotypes.   
3.4 Positive control chemicals  
Chemicals divide in two groups according to their affect mechanisms. These groups are 
direct and indirect acting positive controls.  
Many direct acting agents has been introduced as positive controls because of their high 
specificity for the tester strains. The most common direct-acting positive control chemicals 
for Ames/Salmonella test system are listed in Table 3. 
2-Aminoanthracene (2-AA; CAS# 613-13-8), 2-Aminofluorene (2-AF; CAS# 153-78-6) and 
Aflatoxin B1 (AFB1; CAS# 1162-65-8) are frequently used indirect-acting positive controls 
that requires metabolic activation before react with the Salmonella tester strains (Mortelmans 
& Zeiger, 2000; Ozbek et al., 2008b; Limem et al., 2010). 
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Chemical 
Mechanism of 
Genotoxicity 
Tester 
Strain 
Reference CAS# 
4-Nitro-o-
phenilenediamine 
(4-NPD) 
Teratogenic and 
intercalating 
agent 
TA1538 
TA98 
Ben Sghaier et al., (2010) 
Kaur et al., (2010) 
Mortelmans & Zeiger 
(2000) 
99-56-9 
4-Nitroquinoline 
1-oxide 
(4-NQO) 
Causing DNA 
lesions 
TA1538 
TA100 
TA98 
Oh et al., (2008) 
Ozbek et al., (2008a) 
Brennan & Schiestl (1998) 
56-57-5 
9-Aminoacridine 
(9-AA) 
DNA 
intercalating 
agent 
TA1537 
TA97 
Gulluce et al., (2010) 
Miadokova et al., (2009)  
Mortelmans & Zeiger 
(2000) 
90-45-9 
Methyl methane 
sulfonate 
(MMS) 
Alkylating 
agent 
TA102 
TA104 
Mortelmans & Zeiger 
(2000) 
Dellai et al., (2009) 
Zahin et al., (2010) 
66-27-3 
Mitomycin C 
(MTC) 
DNA cross-
linker and 
alkylating agent 
TA102 
Biso et al., (2010) 
Mortelmans & Zeiger 
(2000) 
Zhang et al., (2011) 
50-07-7 
N-Methyl-N’-
nitro-N-
nitrosoguanidine 
(MNNG) 
Alkylating 
agent 
TA100 
Caldini et al., (2005) 
Duh et al., (2009) 
Oh et al., (2008) 
70-25-7 
Sodium azide 
(NaN3) 
L-azidoalanine 
mediated base 
substitution 
TA1535 
TA100 
Bulmer et al., (2007) 
Gulluce et al., (2010) 
Mortelmans & Zeiger 
(2000) 
26628-22-8 
Table 3. The frequently used direct-acting chemicals for the Salmonella tester strains. 
3.5 Genetic analysis of the Salmonella tester strains  
When a new strain received, its genotypic characteristics (his, rfa and uvrB-bio), spontaneous 
mutation rate and the presence of pKM101 and pAQ1 plasmids should be checked before 
preparation of frozen cultures for long term storage. For this purpose, follow these steps: 
3.5.1 Inchoative stages for genetic analysis 
 Add 1 mL of sterile nutrient broth to rehydrate the lyophilized culture. 
 Transfer 10 µL of the rehydrated culture to nutrient agar plate and strake the inoculum 
to get individual colonies that serve as main sources for the genetic analysis of the tester 
strains. 
 Transfer the rest portion of the rehydrated culture to 4 mL of nutrient broth. This broth 
culture serve as a back-up point in case of there is no growth on the nutrient agar plates. 
 Incubate the cultures overnight at 37 °C. Then, check the agar plates and broth cultures 
for bacterial growth. 
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 At least two purification steps should be made to get more reliable results. Pick one 
healthy looking colony and streak it again on nutrient agar plates or GM agar plates 
supplemented with excess of biotin and histidine. If the tester strain carries pKM101 
and/or pAQ1 plasmids, GM agar plates should be also supplemented with ampicillin 
and/or tetracycline, respectively. However, growth of the tester strains on the 
supplemented GM agar plates takes more time (approximately 48 h) than nutrient agar 
plates; it is recommended because using of them reduces contamination risks.   
3.5.2 Genetic analysis   
Five mandatory steps for all strains and additional one or two steps for plasmid carrying 
strains should be made to perform the best reliable genetic analysis. For this purpose, 
inoculate 5 mL of nutrient broth with a single colony after purification steps, and incubate 
the culture overnight 37 °C. Then, follow these steps for a complete strain check: 
 In the 1st step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of biotin, which demonstrates the histidine dependence (his 
mutation) of all the Salmonella tester strains. After an incubation period at 37 °C for 24-
48 h, there should be no growth on the plate (see Figure 4a).  
 In the 2nd step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of histidine, which demonstrates the biotin dependence (bio 
mutation) of all the Salmonella tester strains except TA102 strain. After an incubation 
period at 37 °C for 24-48 h, there should be no growth on the plate. Due to lack of the bio 
mutation, TA102 strain can be growth on a GM agar plate supplemented with excess of 
histidine (see Figure 4b). 
 In the 3rd step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of biotin and histidine, which demonstrates the biotin and 
histidine dependence (bio and his mutations) of all the Salmonella tester strains. After an 
incubation period at 37 °C for 24-48 h, there should be growth on the plate (see Figure 4c). 
 In the 4th step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of biotin and histidine. Place a sterile filter paper disk in the 
middle of the plate and apply 10 µL crystal violet solution (0.1%, w/v) onto the disk. After 
an incubation period at 37 °C for 24-48 h, all strains show a zone of growth inhibition 
surrounding the disk, which demonstrates the presence of rfa mutation (see Figure 4d). 
 In the 5th step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of biotin and histidine. Unseal the top and cover the half of 
the plate with sterile aluminum foil. Expose the plate to a low level of UV irradiation for 
a short time (approx. 8-10 seconds) that kills the uvrB strain but not its isogenic DNA 
repair proficient strain. After an incubation period at 37 °C for 24-48 h, there should be 
normal growth on the non-exposed part of the plate but not on the exposed part. It 
demonstrates the presence of uvrB mutation. It is known that the source of uvrB 
mutation, a deletion mutation, also covers the biotin gene region. Therefore, if a strain 
shows a positive bio mutation result in the 2nd step, there is no need to check the 
presence of the uvrB mutation for this strain (see Figure 4e). 
 In the 6th step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of biotin, histidine and ampicillin. After an incubation period 
at 37 °C for 24-48 h, there should be growth on the plate, which demonstrates the 
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presence of pKM101 plasmid in the tester strains TA97, TA98, TA100, TA102 and TA104 
(see Figure 4f). 
 In the 7th step, streak a loop of the overnight culture on the surface of a GM agar plate 
supplemented with excess of histidine and tetracycline. After an incubation period at 
37°C for 24-48 h, there should be growth on the plate, which demonstrates the 
presence of pAQ1 plasmid in the tester strain TA102 (see Figure 4f). 
     
(a)     (b) 
     
(c)     (d) 
     
(e)     (f) 
Fig. 4. Demonstration of (a) histidine, (b) biotin and (c) biotin/histidine dependence of the 
Salmonella tester strains, and presence of (d) the rfa mutation, (e) the uvrB mutation, (f) 
pKM101/pAQ1 plasmids. 
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3.5.3 Spontaneous mutation rates    
Each laboratory has its characteristic spontaneous mutation rates for the all tester strains, 
and these values show a wide-range variation among the laboratories. Therefore, the 
spontaneous mutant frequency should be determined for all strains and recorded. It serves 
as historical control values provide choosing suitable strains for mutagenicity and 
antimutagenicity assays. Table 4 shows a sample of acceptable control values for the most 
common Salmonella tester strains. 
Strain 
Number of revertants 
Without metabolic activation With metabolic activation 
TA97 75-200  100-200  
TA98 20-50  20-50  
TA100 75-200  75-200  
TA102 100-300  200-400  
TA104 200-300  300-400  
TA1535 5-20  5-20  
TA1537 5-20  5-20  
TA1538 5-20  5-20  
Table 4. Spontaneous revertant control values for the most common Salmonella tester strains 
(Mortelmans & Zeiger, 2000). 
3.6 Long term storage of the tester strains  
The Salmonella tester strains should be stored in a freezer at -80 °C or liquid nitrogen. Healthy 
looking single colonies should be chosen to prepare the frozen stock cultures. 
Dimethylsulfoxide (DMSO) or glycerol is suggested as cryoprotective agent. The final 
concentration of the cryoprotective should be at least 10% (v/v) (Mortelmans & Zeiger, 2000).  
3.7 Viability assay and determination of test concentrations  
Cytotoxic properties of the test materials toward the Salmonella tester strains should be 
determined before performing mutagenicity and antimutagenicity assays. The viability 
assay includes observations for Salmonella colonies on plates after 48 h incubation at 37 °C. 
Following three main characteristics for the tester strains should be taken into account. 
 Thinning of the background lawn 
 Absence of background lawn 
 Presence of pinpoint non-revertant colonies  
These characteristics indicate toxic levels of the test chemicals, and applicable dose ranges 
should be determined by repeating of the viability assay with lower concentrations of the 
test chemicals (Mortelmans & Zeiger, 2000). 
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3.8 Mutagenicity and antimutagenicity assays 
Various test procedures for Ames/Salmonella test system have been developed to determine 
mutagenic and antimutagenic potency of synthetic and natural chemicals. These procedures 
mainly are based on the physical properties or quantity of the test chemical. For example; the 
desiccator assay has been developed for gases and volatile substances, and Kado assay allows 
studying the chemicals in small amounts. However, the standard plate incorporation method is 
the most common application procedure of the Ames/Salmonella test system (Kado et al., 1983; 
Hughes et al., 1987; Zeiger et al., 1992; Araki et al., 1994; Mortelmans & Zeiger, 2000; Tijs, 2008). 
3.8.1 The standard plate incorporation method 
The method consists of exposing the tester strains to the test chemical directly on a glucose 
agar plate. The main advantages of the method can be listed in giving easy, reproducible, 
reliable and comprehensive results.  
Follow these steps for performing mutagenicity assay (Mortelmans & Zeiger, 2000): 
1. Steps taken prior to performing the experiment 
 Inoculate the tester strain from frozen culture into 5 mL of nutrient broth and 
incubate the new culture overnight at 37 °C.  
 Prepare an appropriate number of labeled GM agar plates and sterile tubes for each 
test chemical. 
 Prepare metabolic activation system and keep on ice until use. 
 Prepare chemical dilutions. 
 Melt top agar supplemented with 0.05 mM histidine and biotin and maintain at 
43 °C to 48 °C. 
2. Add following items respectively into sterile glass tubes maintained at 43 °C and mix 
well each addition*. 
 2 mL of molten top agar 
 0.5 mL of S-9 mix (for the test performed with metabolic activation system) or 
buffer (without activation) 
 0.05 mL of the test chemical dilution 
 0.05-0.10 mL overnight culture of the tester strain (approx. 1-2×108 bacteria per tube 
– A540 0.1-0.2)  
3. Mix well the tubes and pour onto the surface of GM agar plates 
4. When the top agar is solidify, invert and incubate the cultures at 37 °C for 48 h 
5. Count the colonies after incubation and express the results as the number of revertant 
colonies per plate. 
*Notes: This step includes two additional groups which are negative controls and positive 
controls. The negative controls do not include 0.05 mL of the test chemicals, but include the 
solvent at equal quantity. Positive controls also do not include 0.05 mL of the test chemicals, 
but include the suitable positive mutagen solution for the tester strain at equal quantity.  
The procedures of mutagenicity assay are all applicable to the antimutagenicity assay. The 
only procedural difference is the addition of the suitable positive mutagen solution to the all 
test chemical groups (Nagabhushan et al., 1987; Bala & Grover, 1989; Edenharder et al., 1999; 
Edenharder & Grünhage, 2003; Ozbek et al., 2008a, 2008b; Gulluce et al., 2010). 
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4. Conclusion 
In conclusion, the mutant Salmonella strains are beneficial for humanity contrary to their 
pathogenic wild-type strains. The histidine auxotrophic Salmonella typhimurium strains, 
object of the present study, provide a possibility to determine natural and synthetic 
chemicals with mutagenic properties. Similarly, these are also valuable for identification of 
antimutagenic chemicals after minor technical modifications. When a chemical, precious for 
industrial or health applications, is found or synthesized, determination of its genotoxic 
properties has a great importance. In this perspective, the Ames test allows making 
relatively cheap and reliable applications resulting in a short time. 
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